Ticker Details
Liquidia Technologies, Inc.
IPO Date:	July 23, 2018
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$5.42B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.37 | 3.38%
Avg Daily Range (30 D):	$1.37 | 3.05%
Avg Daily Range (90 D):	$1.20 | 3.02%

Institutional Daily Volume
Avg Daily Volume:	.76M
Avg Daily Volume (30 D):	1.31M
Avg Daily Volume (90 D):	1.44M

Trade Size
Avg Trade Size (Sh.):	95
Avg Trade Size (Sh.) (30 D):	58
Avg Trade Size (Sh.) (90 D):	59

Institutional Trades
Total Institutional Trades:	1,180
Avg Institutional Trade:	$2.2M
Avg Institutional Trade (30 D):	$3.1M
Avg Institutional Trade (90 D):	$2.84M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.87M
Avg Closing Trade (30 D):	$5.8M
Avg Closing Trade (90 D):	$5.14M
Avg Closing Volume:	158.89K

News

Apr 8, 2026 @ 5:00 PM Interstitial Lung Disease Market to Witness Accele... Source: Delveinsight

Apr 5, 2026 @ 2:06 PM Liquidia's Chairman Sold Company Shares Worth $2.5... Source: Robert Izquierdo

Mar 28, 2026 @ 3:26 PM The Chief Commercial Officer of Liquidia (LQDA) So... Source: Cory Renauer

Sep 29, 2025 @ 12:30 PM Liquidia to Present Clinical Data from ASCENT Tria... Source: Globe Newswire

Aug 14, 2025 @ 5:00 PM Pulmonary Hypertension associated with Interstitia... Source: Delveinsight

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$.24	$.6	$.17
Diluted EPS	$.16	$.52	$.17
Revenue	$288.07M	$132.87M	$92.02M
Gross Profit
Net Income / Loss	$22.31M	$52.86M	$14.56M
Operating Income / Loss	$45.55M	$61.5M	$19.79M
Cost of Revenue
Net Cash Flow	$56.53M	$32.11M	$33.18M
PE Ratio